Scarica l'app Stockscreener
6.90
1.12%
0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Precedente Chiudi:
$6.82
Aprire:
$6.91
Volume 24 ore:
610.31K
Relative Volume:
0.22
Capitalizzazione di mercato:
$748.90M
Reddito:
$42.51M
Utile/perdita netta:
$-116.49M
Rapporto P/E:
-6.1607
EPS:
-1.12
Flusso di cassa netto:
$-120.82M
1 W Prestazione:
+1.87%
1M Prestazione:
+37.65%
6M Prestazione:
+121.04%
1 anno Prestazione:
-29.27%
Intervallo 1D:
$6.77
$7.10
Intervallo di 1 settimana:
$6.36
$7.105
Portata 52W:
$1.03
$12.02
Tango Therapeutics Inc Stock (TNGX) Company Profile
Nome
Tango Therapeutics Inc
Settore
Industria
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Confronta TNGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.909 | 739.25M | 42.51M | -116.49M | -120.82M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.07 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.18 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.90 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.29 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.75 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-17 | Iniziato | Jefferies | Buy |
| 2024-04-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Iniziato | Piper Sandler | Overweight |
| 2023-12-08 | Iniziato | B. Riley Securities | Buy |
| 2022-10-20 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Does Tango Therapeutics Inc. stock perform well during market downturnsMaximize gains with proven stock analysis - jammulinksnews.com
Risk vs reward if holding onto Tango Therapeutics Inc.Yearly Trend Summary and Opportunity Breakdown - Newser
Can Tango Therapeutics Inc. stock recover from recent declineLow Risk Trade Timing with Analysis Metrics - Newser
Will Tango Therapeutics Inc. stock benefit from interest rate changes 2-Day Signal Watch with Forecast Outcome - Newser
Tango Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive Weekly Growth Portfolio Performance Summary - Newser
What institutional investors are buying Tango Therapeutics Inc. stockTop Growth Opportunities For Fast Growth - jammulinksnews.com
Price action breakdown for Tango Therapeutics Inc. Free Beginner Friendly Stock Selection Guide - Newser
How does Tango Therapeutics Inc. generate profit in a changing economyMarket-beating performance - jammulinksnews.com
What are the latest earnings results for Tango Therapeutics Inc.Invest confidently with real-time data - jammulinksnews.com
What are Tango Therapeutics Inc. company’s key revenue driversUnlock exclusive stock analysis for investors - jammulinksnews.com
Should I hold or sell Tango Therapeutics Inc. stock in 2025Explosive capital appreciation - jammulinksnews.com
What are analysts’ price targets for Tango Therapeutics Inc. in the next 12 monthsNavigate market shifts with confidence - jammulinksnews.com
How high can Tango Therapeutics Inc. stock price go in 2025Trade With Low Risk Exposure - Newser
Will Tango Therapeutics Inc. stock benefit from interest rate changesFree Best Performing Stock Suggestions - Newser
Tango Therapeutics Inc. Company Revenue and Profit Trends: A Deep DiveFree Stock Trading Signals - Newser
What drives Tango Therapeutics Inc. stock priceMassive portfolio appreciation - Autocar Professional
Tango Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - PrintWeekIndia
Will Tango Therapeutics Inc. stock benefit from AI tech trendsSuperior capital gains - jammulinksnews.com
Is Tango Therapeutics Inc. a good long term investmentPhenomenal investment performance - PrintWeekIndia
What analysts say about Tango Therapeutics Inc. stockExplosive portfolio gains - Autocar Professional
Optimistic Investors Push Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Up 31% But Growth Is Lacking - 富途牛牛
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - The Manila Times
Tango Therapeutics Earnings Alert: Q2 2025 Results Coming August 5 Without Investor Call - Stock Titan
How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tango Therapeutics Inc Azioni (TNGX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Barry Douglas | General Counsel |
Feb 05 '25 |
Sale |
3.16 |
2,556 |
8,081 |
66,014 |
| Beckman Daniella | Chief Financial Officer |
Feb 04 '25 |
Sale |
2.99 |
4,284 |
12,801 |
154,232 |
| Beckman Daniella | Chief Financial Officer |
Feb 05 '25 |
Sale |
3.16 |
3,948 |
12,481 |
150,284 |
| Crystal Adam | See Remarks |
Feb 04 '25 |
Sale |
2.99 |
7,432 |
22,207 |
165,061 |
| Crystal Adam | See Remarks |
Feb 05 '25 |
Sale |
3.16 |
6,851 |
21,659 |
158,210 |
| Weber Barbara | Chief Executive Officer |
Feb 04 '25 |
Sale |
2.99 |
9,778 |
29,217 |
1,631,264 |
| Weber Barbara | Chief Executive Officer |
Feb 05 '25 |
Sale |
3.16 |
9,013 |
28,494 |
1,622,251 |
| Rothenberg Mace | Director |
Nov 18 '24 |
Buy |
3.78 |
10,000 |
37,800 |
31,250 |
| Rothenberg Mace | Director |
Nov 14 '24 |
Buy |
3.62 |
10,000 |
36,200 |
21,250 |
| EcoR1 Capital, LLC | 10% Owner |
Nov 06 '24 |
Sale |
3.28 |
1,494,558 |
4,896,023 |
11,836,178 |
0.49%
1.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):